#VisualAbstract: Upper neck irradiation is noninferior to whole neck irradiation for newly diagnosed nasopharyngeal carcinoma

byTeddy Guo

May 4, 2022

in StudyGraphics

Reading Time: 1 min read

Exercise interventions are currently being poorly reported in the literature

RelatedReports

StudyGraphics

#VisualAbstract: Induction chemotherapy with erlotinib does not improve survival in stage III-IV head and neck squamous cell carcinoma

September 27, 2022

StudyGraphics

#VisualAbstract: Induction chemotherapy with cisplatin plus gemcitabine in addition to concurrent chemotherapy improves survival for nasopharyngeal carcinoma

September 20, 2022

Chronic Disease

#VisualAbstract: Pembrolizumab-based therapy is more effective with increasing PD-L1 expression in head and neck squamous cell carcinomas

September 6, 2022

Imaging and Intervention

Radiotherapy alone noninferior to concurrent chemoradiotherapy survival without disease relapse in patients with low-risk nasopharyngeal carcinoma

August 28, 2022

Classics Series, Landmark Trials in Medicine

The ACCORD trial: Intensive glucose control associated with increased mortality [Classics Series]

Novel coronavirus identified from patients with pneumonia in Wuhan, China

More severe symptoms and hospitalizations seen during period of COVID-19 delta variant dominance compared to omicron

#VisualAbstract: Canakinumab treatment did not reduce pain to clinical significance but shows anti-inflammatory effects in children and young adults with sickle cell anemia

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

#VisualAbstract: Upper neck irradiation is noninferior to whole neck irradiation for newly diagnosed nasopharyngeal carcinoma

#VisualAbstract: Induction chemotherapy with erlotinib does not improve survival in stage III-IV head and neck squamous cell carcinoma

#VisualAbstract: Induction chemotherapy with cisplatin plus gemcitabine in addition to concurrent chemotherapy improves survival for nasopharyngeal carcinoma

#VisualAbstract: Pembrolizumab-based therapy is more effective with increasing PD-L1 expression in head and neck squamous cell carcinomas

Exercise interventions are currently being poorly reported in the literature

The ACCORD trial: Intensive glucose control associated with increased mortality [Classics Series]

RelatedReports

#VisualAbstract: Induction chemotherapy with erlotinib does not improve survival in stage III-IV head and neck squamous cell carcinoma

#VisualAbstract: Induction chemotherapy with cisplatin plus gemcitabine in addition to concurrent chemotherapy improves survival for nasopharyngeal carcinoma

#VisualAbstract: Pembrolizumab-based therapy is more effective with increasing PD-L1 expression in head and neck squamous cell carcinomas

Radiotherapy alone noninferior to concurrent chemoradiotherapy survival without disease relapse in patients with low-risk nasopharyngeal carcinoma

The ACCORD trial: Intensive glucose control associated with increased mortality [Classics Series]

More severe symptoms and hospitalizations seen during period of COVID-19 delta variant dominance compared to omicron

#VisualAbstract: Canakinumab treatment did not reduce pain to clinical significance but shows anti-inflammatory effects in children and young adults with sickle cell anemia

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2MM+ Premium Access

Recent Reports

#VisualAbstract: Upper neck irradiation is noninferior to whole neck irradiation for newly diagnosed nasopharyngeal carcinoma

RELATED REPORTS

Exercise interventions are currently being poorly reported in the literature

The ACCORD trial: Intensive glucose control associated with increased mortality [Classics Series]

RelatedReports

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2MM+ Premium Access

Recent Reports